Aligos therapeutics to present at the jefferies 2023 healthcare conference

South san francisco, calif., may 24, 2023 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that lawrence m. blatt, ph.d., mba, chairman and ceo of aligos, will present at the jefferies healthcare conference on thursday, june 8, 2023 at 8:00 a.m. et.
ALGS Ratings Summary
Quant
ALGS Quant Ranking
Sector
Industry
Quant Rating
Quant Score